GSA CAPITAL PARTNERS LLP - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 46 filers reported holding VYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$154,000
-30.6%
236,292
+8.5%
0.02%
-25.0%
Q4 2021$222,000
+73.4%
217,747
+135.7%
0.03%
+115.4%
Q3 2021$128,00092,4020.01%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,551,000$2,602,0002.01%
Perceptive Advisors 4,356,044$4,444,0000.03%
GSA CAPITAL PARTNERS LLP 217,747$222,0000.03%
Virtu Financial LLC 175,278$179,0000.02%
XTX Topco Ltd 17,053$17,0000.01%
SkyOak Wealth, LLC 27,200$28,0000.01%
DELTEC ASSET MANAGEMENT LLC 30,000$31,0000.01%
Tekla Capital Management LLC 135,395$138,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$64,0000.00%
TWO SIGMA SECURITIES, LLC 47,475$48,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders